TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
about
Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensationFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersAFAP1 Is a Novel Downstream Mediator of TGF-β1 for CCN2 Induction in OsteoblastsTransforming growth factor-beta induces cellular injury in experimental diabetic neuropathyTenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1Corticosteroid-regulated genes in rat kidney: mining time series array data.Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.CREB trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of CTGF transcription in mesangial cells.Activation of the connective tissue growth factor (CTGF)-transforming growth factor β 1 (TGF-β 1) axis in hepatitis C virus-expressing hepatocytes.miR-205 expression promotes cell proliferation and migration of human cervical cancer cellsSenescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.Induction of TGF-beta1 in the trabecular meshwork under cyclic mechanical stressMolecular mechanisms and in vivo mouse models of skin aging associated with dermal matrix alterations.The matrix-binding domain of microfibril-associated glycoprotein-1 targets active connective tissue growth factor to a fibroblast-produced extracellular matrixGrowth factors and the development of diabetic nephropathy.The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.The pathogenesis of fibrosis and renal disease in scleroderma: recent insights from glomerulosclerosis.Protective effects of calcitriol on diabetic nephropathy are mediated by down regulation of TGF-β1 and CIP4 in diabetic nephropathy rat.Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction.Cdc42-interacting protein-4 promotes TGF-Β1-induced epithelial-mesenchymal transition and extracellular matrix deposition in renal proximal tubular epithelial cells.Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts.Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.The role of tubular epithelial-mesenchymal transition in progressive kidney disease.Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactionsGenetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetesProteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?The role of epigenetics in the fibrotic processes associated with glaucoma.The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor-beta1.Parathyroid hormone-related protein promotes epithelial-mesenchymal transitionExpression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.Epithelial vs myofibroblast differentiation in immortal rat lung cell lines--modulating effects of bleomycin.Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin.
P2860
Q23914493-FB9FB46E-BF7F-4936-9A47-B494D87AD541Q24644869-79E986E4-27E7-47EA-8E9D-49A65EC62174Q28387809-8FC0B361-319A-4E45-A2FC-08A99E164C23Q28575618-07887D57-B844-4045-AB11-A4D5C3292724Q28771732-733949AB-7C3B-4511-BBEB-1616BCF77843Q30993150-3A65C51E-51D9-4238-A99B-9B893C665D64Q33357303-79EE5A68-59FB-4672-9C4E-628F32CA84B7Q33722844-38FED3E5-D538-4E43-A2D9-7C84D431AE8CQ33727860-6E8AFF16-ACA3-4112-8516-A2D62F171629Q34441588-D101A8BD-CD62-43EA-AE03-7B84067BF855Q34442631-055D46AD-E01A-460F-8E9E-AEE70604178BQ34520210-5B283349-A786-4FB7-A36B-B6757F1ECDB3Q34679061-21833F21-8052-48BE-ABA4-41F46D045B4CQ35005695-9CFCF9DE-7340-4361-82CD-3EAF59759385Q35103591-39ED2D38-BDCC-461A-8732-E8CE0D13E3C2Q35128563-D7982097-3759-45D5-A46E-A35C2836D8A0Q35134901-53232B75-3ADC-4646-869F-FBE963C8D066Q35168377-99F63401-A96C-44A5-ADA2-E4441033C157Q35581294-038C8E05-D969-43C0-A3EB-13A077111093Q35642059-407D0C03-9097-4EDC-B2C8-2D7256399F2FQ35689005-0C1B141C-C768-4220-B2A4-914BAC877A37Q35740907-5D92DB6F-C3BD-433A-A7E1-B583D3B29926Q35881771-6E400345-4691-4CAB-B166-8F5E22B02A58Q36063721-9D1636E3-9C7C-4571-9535-88ECC0545E7EQ36299449-F5242CC2-7A70-476B-82E3-A418DF8E76BAQ36661077-2C7CF78C-5820-4DB6-8D90-024F5FA33FF8Q36689039-07FF71E6-F7FC-41A6-9930-25448C8D5F65Q36724904-E5753982-765A-4FC7-AE67-5929B7AA7617Q36857879-2EBC6D79-4E9D-4C04-8327-473D626B27C2Q36927753-FD042F8A-50C1-4522-9552-CE1AEF8BEEBEQ37310058-DDB1F78D-0DB9-4F7A-9DFA-C8E2B95B4752Q37415689-CB046613-1DF5-4072-B0F1-78F419CEA311Q38019401-E6D22B99-707B-4504-8A6F-DCFBCD8D53A4Q38209671-50986B68-02CE-4F4E-B2E0-28761EB0A290Q38301827-8B1CD209-6C12-423B-88B0-999A49673BBEQ39485658-89B7519E-9D00-4616-B072-838B9EA4F88AQ39671343-4A7E8701-8D34-40A9-AFB6-61BD068B2833Q39960357-D22440A9-2E0E-45D9-B013-1F7A37C36A52Q40368446-545836F8-A697-43AA-BEBE-9FFE1B0D850FQ40784883-849C60A2-9BF6-4327-B3A5-47D27F422560
P2860
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@en
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@nl
type
label
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@en
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@nl
prefLabel
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@en
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@nl
P2093
P2860
P1476
TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.
@en
P2093
Daniel Shegogue
Debra Hazen-Martin
Eddie L Greene
Elizabeth Gore-Hyer
Gary Grotendorst
Malgorzata Markiewicz
Shianlen Lo
P2860
P304
P356
10.1152/AJPRENAL.00007.2002
P577
2002-10-01T00:00:00Z